U.S. Stock News

NYSE:W
NYSE:WSpecialty Retail

Wayfair (W) Losses Keep Margins In Focus As Bulls Lean On 45% Earnings Growth Outlook

Wayfair (W) has opened 2026 earnings season with Q1 results that come on the heels of Q4 2025 revenue of US$3.3b and a basic EPS loss of US$0.89, alongside trailing 12 month revenue of US$12.5b and a basic EPS loss of US$2.45. Over the past year, the company has seen quarterly revenue range from US$2.7b to US$3.3b, while basic EPS has moved between a small profit of US$0.12 and losses of up to US$1.02. This sets a clear backdrop of high sales volumes but thin and often negative margins that...
NYSE:IBM
NYSE:IBMIT

IBM Expands MIT AI And Quantum Research Link To Enterprise Delivery

IBM (NYSE:IBM) and MIT launched the MIT IBM Computing Research Lab, expanding their collaboration in AI, algorithms, and quantum computing. The new lab focuses on foundational research that seeks to move beyond current classical computing limits, with potential applications across sectors such as healthcare and materials science. IBM plans to create 750 tech roles and open its FutureNow innovation center within the Illinois Quantum and Microelectronics Park in Chicago. For investors...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

GE HealthCare (GEHC) Is Down 12.9% After Cutting 2026 Profit Outlook And Reshaping Imaging Portfolio

In late April 2026, GE HealthCare Technologies reported first-quarter 2026 results showing revenue rising to US$5.13 billion from US$4.78 billion a year earlier, while net income declined to US$389 million and basic earnings per share fell to US$0.85 as profitability came under pressure. Alongside the earnings miss and reduced full-year profit outlook, the company reshaped its portfolio and leadership by creating a new US$14.60 billion Advanced Imaging Solutions segment, advancing AI- and...
NYSE:CRM
NYSE:CRMSoftware

Salesforce’s Anthropic Bet And What It Could Mean For CRM Valuation

Salesforce (NYSE:CRM) was an early investor in Anthropic, the AI company behind the Claude large language models. Anthropic is reportedly preparing for a public listing that could carry a very large valuation. This ties Salesforce directly to one of the most talked about AI IPO candidates in the current market. Salesforce runs a large customer relationship management platform and has been incorporating AI into sales, service, marketing and analytics tools for years. Its early backing of...
NYSE:FLS
NYSE:FLSMachinery

Flowserve (FLS) Margin Expansion To 7.6% Tests Bullish Earnings Leverage Narrative

Flowserve (FLS) opened 2026 with Q1 revenue of US$1.1b and basic EPS of US$0.64, setting a clear marker for the year ahead. Over the past year, revenue has moved from US$1.18b in Q1 2025 to US$1.07b in Q1 2026, while basic EPS has shifted from US$0.56 to US$0.64, giving investors a fresh read on how the earnings profile is evolving. With trailing net income of US$354.0m and margins influenced by both underlying operations and prior one off items, the focus now is on how efficiently Flowserve...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Q1 Profit Swing Challenges High Valuation Bear Narratives

Bloom Energy (BE) opened 2026 with Q1 revenue of US$751.1 million and basic EPS of US$0.25, alongside net income of US$70.7 million. On a trailing 12 month basis, revenue was US$2.4 billion with basic EPS of US$0.02 and net income of US$6.0 million. Over the past year, the company’s quarterly revenue moved from US$326.0 million in Q1 2025 to US$751.1 million in Q1 2026, while basic EPS shifted from a loss of US$0.10 to a profit of US$0.25. Trailing 12 month EPS moved from a loss of US$0.13 to...
NYSE:HTGC
NYSE:HTGCCapital Markets

Are Dividends Amid Lawsuits Altering The Investment Case For Hercules Capital (HTGC)?

Hercules Capital, Inc. recently declared a past quarterly dividend of US$0.4000 per share and a past special dividend of US$0.0700 per share, both paid on May 21, 2026, to shareholders of record as of May 14, 2026. At the same time, Hercules is facing multiple securities class action lawsuits alleging it overstated due diligence and portfolio valuations, raising questions about the robustness of its lending and valuation practices. Against this backdrop of dividend payouts and allegations of...
NYSE:GS
NYSE:GSCapital Markets

Goldman Sachs Expands AI Exposure With Aidoc And Hightouch Investments

Goldman Sachs (NYSE:GS) has led major funding rounds in Aidoc, a clinical AI platform, and Hightouch, an AI-driven marketing automation provider. The alternatives unit at Goldman Sachs anchored a US$150 million round for Aidoc and a fundraising round above US$150 million for Hightouch. These transactions expand the bank's exposure to enterprise AI and digital transformation across healthcare and marketing technology. For you as an investor, these moves show how Goldman Sachs is leaning...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Is It Too Late To Consider Amazon.com (AMZN) After A 39% One Year Rally?

If you are wondering whether Amazon.com at US$265.06 is still reasonably priced or already reflecting a lot of optimism, this breakdown will help you frame that question clearly. The stock has recorded returns of 3.9% over the last 7 days, 27.3% over the last 30 days, 17.0% year to date and 39.4% over the last year. This naturally raises questions about how much value is already reflected in the price. Recent news coverage has focused on Amazon.com's broad role across e commerce, cloud...
NYSE:HUN
NYSE:HUNChemicals

Assessing Huntsman (HUN) Valuation After Wider Q1 2026 Loss And Modest Sales Uptick

Why Huntsman’s latest earnings matter for shareholders Huntsman (HUN) just reported first quarter 2026 results, with sales of US$1,420 million and a net loss of US$53 million, compared with a US$5 million loss a year earlier. See our latest analysis for Huntsman. Huntsman’s 1-day share price return of 8.45% and year to date share price return of 41.02% suggest momentum has picked up recently. However, the 5 year total shareholder return of a 43.55% decline points to a weaker longer run...
NYSE:KO
NYSE:KOBeverage

Coca-Cola Earnings Beat Highlights Zero Sugar Growth And Africa Exit Plans

Coca-Cola (NYSE:KO) reported Q1 2026 earnings that outperformed prior expectations and raised its full year profit outlook. The company highlighted rapid growth in its zero sugar and premium product lines, with Coca-Cola Zero Sugar delivering double digit growth as a key product success. Management pointed to continued resilience in the face of geopolitical disruption and differences in consumer spending patterns across markets. Coca-Cola is preparing for a major shift in H2 2026 with the...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Is Analog Devices (ADI) Pricing In Too Much Optimism After Its Recent Share Price Surge

If you are wondering whether Analog Devices at around US$402 per share looks expensive or attractive, the answer depends on how you think about value, not just price. The stock has been volatile recently, with a 0.4% decline over the last 7 days, but a 26.4% gain over 30 days, 46.9% year to date, and returns of 110.8% over 1 year, 133.3% over 3 years, and 182.1% over 5 years. Recent coverage has focused on Analog Devices as a key name in semiconductors, with attention on how its technology...
NYSE:MANU
NYSE:MANUEntertainment

Manchester United (NYSE:MANU) Valuation Check As Recent Share Gains Meet Mixed Pricing Signals

Recent share performance snapshot Manchester United (NYSE:MANU) has seen its share price move recently, with a last close of US$18.88. Over the past month and the past 3 months, the stock has recorded total returns of 12.2% and 6.7% respectively. See our latest analysis for Manchester United. For context, the recent 1 month share price return of 12.2% and year to date share price return of 19.65% sit alongside a 1 year total shareholder return of 37.11%, while the 3 year total shareholder...
NYSE:ASAN
NYSE:ASANSoftware

A Look At Asana (ASAN) Valuation As Short Squeeze Interest And Waning Selling Pressure Attract Fresh Attention

Why a potential short squeeze is putting Asana (ASAN) on watch Asana (ASAN) is drawing renewed attention after analysis highlighted short interest above 30% and a relatively tight float, given founder Dustin Moskovitz’s large controlling stake. Together, these factors raise the potential for a short-squeeze setup. See our latest analysis for Asana. Despite renewed interest around a potential short squeeze and recent board changes taking effect at the June 2026 annual meeting, Asana’s 1-year...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen’s Legal and Public Sector Shake-Up Might Change The Case For Investing In Lumen (LUMN)

Lumen Technologies announced that Executive Vice President and Chief Legal Officer & Head of Public Sector Mark Hacker has retired to pursue ministry, with Senior Vice President Jennifer Hodges promoted to Executive Vice President and Chief Legal Officer and Jeff Sharritts assuming Public Sector responsibilities as of April 20, 2026. This reshuffle consolidates legal, governance, and public sector oversight under leaders with deep corporate and telecom experience, potentially influencing how...
NasdaqCM:HYMC
NasdaqCM:HYMCMetals and Mining

A Look At Hycroft Mining (HYMC) Valuation After Major Resource Upgrade And Project Progress

Hycroft Mining Holding (HYMC) is back in focus after Q1 2026 results highlighted a 55% increase in measured and indicated gold and silver resources, alongside continued work on underground mining options in Nevada. See our latest analysis for Hycroft Mining Holding. The stock has been volatile around these updates, with a 6.6% 1 day share price return and a 49.4% year to date share price return, while the 1 year total shareholder return is very large. Recent exploration and resource news...
NYSE:BX
NYSE:BXCapital Markets

Blackstone Extends Reach Into Life Sciences And AI Data Infrastructure

Blackstone (NYSE:BX) committed up to US$400 million to Teva's autoimmune drug program in a recent life sciences deal. The firm also arranged a US$2 billion, utility backed power financing package for QTS data centers to support AI focused capacity. These transactions sit alongside Blackstone's traditional alternatives platform and indicate additional sector exposure in health and digital infrastructure. For investors, these moves illustrate how NYSE:BX is putting capital to work in areas...
NYSE:WBS
NYSE:WBSBanks

Assessing Webster Financial (WBS) Valuation After Q1 2026 Earnings And Dividend Reaffirmation

Q1 earnings and dividend decision set the tone for Webster Financial Webster Financial (WBS) has just combined fresh first quarter 2026 results with a reaffirmed cash dividend, giving you updated information on earnings quality, balance sheet trends, and ongoing capital returns. See our latest analysis for Webster Financial. Webster Financial's recent first quarter earnings and dividend announcement come after a 10.02% 90 day share price return and a 55.60% total shareholder return over the...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Evaluating ON Semiconductor (ON) After New Geely And NIO Electric Vehicle Partnerships

ON Semiconductor (ON) is back in focus after deepening its collaborations with automakers Geely and NIO, which are integrating the company’s EliteSiC power technologies into high voltage electric vehicle platforms. See our latest analysis for ON Semiconductor. These EV collaborations are landing at a time when momentum in ON Semiconductor’s shares is already strong, with a 30 day share price return of 62.81% and a 1 year total shareholder return of 154.57% pointing to shifting expectations...
NasdaqGS:NAVN
NasdaqGS:NAVNHospitality

Is Navan (NAVN) Share Price Moves Justified By Current Growth Assumptions

If you are wondering whether Navan is fairly priced or offering hidden value at its current level, it helps to look beyond the headline share price and into what different valuation methods are signaling. Navan’s stock recently closed at US$17.49, with returns of 12.9% over the past 7 days, 32.1% over the past 30 days, and 7.6% year to date. This performance has likely caught the attention of investors watching for changes in sentiment and risk appetite. These moves sit against a backdrop...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma’s Q2 2026 Dividend Raises a Deeper Question About Its Capital Allocation Strategy (RPRX)

Royalty Pharma plc recently approved a second-quarter 2026 dividend of US$0.235 per Class A ordinary share, payable on June 10, 2026, to shareholders of record as of May 15, 2026. This dividend affirmation, alongside increased analyst optimism around upcoming first-quarter 2026 earnings, highlights Royalty Pharma’s focus on cash returns while markets reassess its royalty-driven model and risk profile. We’ll now examine how the confirmed Q2 2026 dividend supports Royalty Pharma’s investment...